期刊论文详细信息
| Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease | |
| PCSK9 Inhibitors in Lipid Management of Patients With Diabetes Mellitus and High Cardiovascular Risk: A Review | |
| Norman E. Lepor1 Yehuda Handelsman2 | |
| [1] Cedars‐Sinai Heart Institute Beverly Hills CA;Metabolic Institute of America Tarzana CA; | |
| 关键词: alirocumab; cardiovascular outcomes; diabetes mellitus; evolocumab; proprotein convertase subtilisin/kexin type 9 inhibitors; | |
| DOI : 10.1161/JAHA.118.008953 | |
| 来源: DOAJ | |
【 授权许可】
Unknown
878987797
028-85220240
